Timing of β-Blocker Reintroduction and the Occurrence of Postoperative Atrial Fibrillation after Cardiac Surgery: A Prospective Cohort Study

WHAT WE ALREADY KNOW ABOUT THIS TOPICβ-blockers are usually stopped in cardiac surgical patientsWhen best to reintroduce them remains unknown, and is a trade-off between hemodynamic risk and development of atrial fibrillation WHAT THIS ARTICLE TELLS US THAT IS NEWThere was little advantage to reintr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anesthesiology (Philadelphia) 2020-02, Vol.132 (2), p.267-279
Hauptverfasser: Couffignal, Camille, Amour, Julien, Ait-Hamou, Nora, Cholley, Bernard, Fellahi, Jean-Luc, Duval, Xavier, Costa De Beauregard, Yolande, Nataf, Patrick, Dilly, Marie-Pierre, Provenchère, Sophie, Montravers, Philippe, Mentré, France, Longrois, Dan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:WHAT WE ALREADY KNOW ABOUT THIS TOPICβ-blockers are usually stopped in cardiac surgical patientsWhen best to reintroduce them remains unknown, and is a trade-off between hemodynamic risk and development of atrial fibrillation WHAT THIS ARTICLE TELLS US THAT IS NEWThere was little advantage to reintroducing β-blockers within 48 hThe odds of atrial fibrillation were significantly reduced by restarting β-blockers between 72 and 96 h after surgery BACKGROUND:For cardiac surgery patients under chronic β-blocker therapy, guidelines recommend their early postoperative reintroduction to decrease the incidence of postoperative atrial fibrillation. The authors hypothesized that the timing of β-blocker reintroduction affects their effectiveness on the incidence of postoperative atrial fibrillation. METHODS:This multicenter prospective French cohort study included patients on β-blockers (more than 30 days before surgery) in sinus rhythm without a pacemaker. The primary outcome, time sequence of β-blocker reintroduction, was analyzed for 192 h after surgery. The secondary outcome, relationship between the occurrence of postoperative atrial fibrillation and timing of β-blocker reintroduction, was analyzed based on pre- and intraoperative predictors (full and selected sets) according to landmark times (patients in whom atrial fibrillation occurred before a given landmark time were not analyzed). RESULTS:Of 663 patients, β-blockers were reintroduced for 532 (80%) but for only 261 (39%) patients in the first 48 h after surgery. Median duration before reintroduction was 49.5 h (95% CI, 48 to 51.5 h). Postoperative atrial fibrillation or death (N = 4) occurred in 290 (44%) patients. After performing a landmark analysis to take into account the timing of β-blocker reintroduction, the adjusted odds ratios (95% CI) for predictor full and selected (increased age, history of paroxysmal atrial fibrillation, and duration of aortic cross clamping) sets for the occurrence of postoperative atrial fibrillation wereadjusted odds ratio (full) = 0.87 (0.58 to 1.32; P = 0.517) and adjusted odds ratio (selected) = 0.84 (0.58 to 1.21; P = 0.338) at 48 h; adjusted odds ratio (full) = 0.64 (0.39 to 1.05; P = 0.076) and adjusted odds ratio (selected) = 0.58 (0.38 to 0.89; P = 0.013) at 72 h; adjusted odds ratio (full) = 0.58 (0.31 to 1.07; P = 0.079) and adjusted odds ratio (selected) = 0.53 (0.31 to 0.91; P = 0.021) at 96 h. CONCLUSIONS:β-Blockers were reintroduced early (after less than 48 h)
ISSN:0003-3022
1528-1175
DOI:10.1097/ALN.0000000000003064